CYTOSORBENTS CORPORATION Adjustments to Additional Paid in Capital, Other
CYTOSORBENTS CORPORATION (CTSO) reported Adjustments to Additional Paid in Capital, Other of -$620.56 thousand for the 12-month period ending 2006-12-31, per its 10-K filed 2013-04-03.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2013-04-03
- CYTOSORBENTS CORPORATION adjustments to additional paid in capital, other for fiscal 2006 was -$620.56K.
| Period end | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|
| 2006-12-31 | -$620.56K 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |